{"disease":{"id":"apeced","name":"apeced"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01386437","title":"Natural History of Individuals With Immune System Problems That Lead to Fungal Infections","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT01953016","title":"Participation in a Research Registry for Immune Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":716,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT05398809","title":"Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03751683","title":"Evaluation Genotypic, Phenotypic and Prognosis APECED Syndrome","phase":"","overall_status":"COMPLETED","enrollment_count":29,"lead_sponsor_name":"University Hospital, Lille","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}